Jpmorgan Chase & CO Molecular Partners Ag Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Dec 26, 2024
BUY
$3.53 - $4.62 $3 - $4
1 New
1 $0
Q4 2023

Feb 12, 2024
BUY
$3.53 - $4.62 $3 - $4
1 New
1 $0

Others Institutions Holding MOLN

# of Institutions
6
Shares Held
849K
Call Options Held
0
Put Options Held
0
View Full List

About MOLECULAR PARTNERS AG

MOLN Quotes by TradingView
  • Ticker MOLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,514,000
  • Market Cap $173M
  • Description
  • Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...
More about MOLN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email